S&P Global: Startup Funding Shifts in 2026
S&P Global forecasts 2026 startup funding. Learn why investors prioritize profit, not hyper-growth, and how $75B targets AI.
S&P Global forecasts 2026 startup funding. Learn why investors prioritize profit, not hyper-growth, and how $75B targets AI.
TOYO invests $500M in solar suppliers. Will this boost production 30% by 2027 and secure market leadership? See what's next for solar.
2026's inverted yield curve impacts startups. Learn how to conserve cash, attract investors, and find M&A opportunities in a tough market.
Ocean tech funding surged to $3.5B in 2025. See why marine inventory startups attract early-stage capital and Asia-Pacific leads investment.
Biotech funding is shifting $3.4B to public health. Learn why current models fail societal needs and what BARDA's increased investment means.
Startup funding is drying up. Learn why PPI pressures are hitting capital raising, how valuations dropped 25%, and what founders must do now.
Iambic's $175M IPO signals new biotech funding rules. Learn what makes AI drug discovery attractive and what future startups need to succeed.
Iambic's $2.5B IPO signals a new biotech era. Learn what drives premium valuations now, distinguishing true innovation from speculation.
Iambic's 2026 IPO shows biotech's market challenges. Learn how companies like Iambic overcome investor skepticism and regulatory hurdles.
Why 10-year Treasury yields above 4.5% mean less cheap capital for startups. Learn what founders must do to survive and attract investors.